TD
Insider
Travis Dalton
Pres., CEO & Executive ChairTravis Dalton (Pres., CEO & Executive Chair) filed 4 Form 4 reports in the trailing twelve months (4 purchases, 0 sales), most often in Claritev Corporation (CTEV). Across 3 priced purchase filings, the average 21-session return was +45.8% from execution and +31.5% from disclosure (delay-adjusted; derived). The largest single filing was $259K of CTEV (20,920 sh across 2 lots, as filed), executed May 18.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+45.8%
avg across 3 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+31.5%
same 3 filings, from disclosure
Filings, ttm
4
4 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$883K
shares × price, as filed
Last traded
Aug 27
Filed Aug 31
Median ADV $4.5M across their filed names
Impact on $10,000 · 12M
$19,647 (+96.5%)
S&P 500 $11,725 (+17.2%) · 79.2 pts ahead
Travis Dalton
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $1.2M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
CTEV
Claritev Corporation
CTEV · 6 buys · 0 sells
6 filings
Recent filings
CTEVPURCHASE
Claritev Corporation
View filing →
$175K4,500 sh × $38.81
Exec Aug 27
Filed Aug 31 · 8:50 AM ET CTEVPURCHASE Claritev Corporation View filing → $259K
20,920 sh across 2 lots
Exec May 18
Filed May 19 · 4:07 PM ET CTEVPURCHASE Claritev Corporation View filing → $200K
15,380 sh × $13.00
Exec Feb 27
Filed Mar 2 · 4:38 PM ET CTEVPURCHASE Claritev Corporation View filing → $250K
5,290 sh × $47.23
Exec Nov 20 2025
Filed Nov 20 2025 · 5:57 PM ET CTEVPURCHASE Claritev Corporation View filing → $232K
3,982 sh × $58.30
Exec Aug 11 2025
Filed Aug 12 2025 · 4:19 PM ET CTEVPURCHASE Claritev Corporation View filing → $101K
5,252 sh × $19.20
Exec Mar 7 2025
Filed Mar 10 2025 · 5:30 PM ET